Injective promoted its newly updated technical whitepaper on November 18 as it sought to build on the recent Nasdaq debut of the Canary Staked INJ ETF (INJC).
Launched on November 5, 2026, the fund, managed by Canary Capital, gives traditional investors direct exposure to the INJ token through regular brokerage accounts. This allows them to invest without managing private keys or setting up cryptocurrency wallets.
$INJC is the first official U.S. listed Injective ETF. If you’re new to $INJ, start with the source.
The new Whitepaper explains how Injective issues real world assets and gives them utility across markets, apps and AI agents.
Full whitepaper 👇 https://t.co/122kwbXBhB
— Injective 🥷 (@injective) November 18, 2026
BitGo serves as the fund’s institutional custodian, while at least 90% of its spot INJ holdings are staked to earn network validation rewards. These rewards are automatically reflected in the fund’s net asset value.
Meanwhile, other US ETF proposals from asset managers such as 21Shares and REX-Osprey remain under regulatory review. Against this backdrop, Injective is using its first major whitepaper update since 2018 to explain its technology and attract investors from traditional finance.
Injective updates its whitepaper to connect traditional finance with blockchain
The arrival of a Nasdaq-listed ETF creates an opportunity for Injective to reach investors beyond the cryptocurrency market. However, many traditional investors may be unfamiliar with the network and its technology.
To address this, Injective is encouraging new investors to read its updated whitepaper, which explains its vision for a finance-focused Layer-1 blockchain.
On X, Chephunme highlighted this opportunity, noting that INJC is the first official US-listed Injective ETF. The user suggested that people discovering INJ through this Wall Street milestone should read the new research to understand the project’s goals and technology.
$INJC is the first official US-listed Injective ETF. 🥷
If you’re discovering $INJ through this milestone, it’s worth going back to the source.
@injective Research has a new whitepaper explaining the architecture behind its vision for a finance-native Layer-1 blockchain.
🧵👇 https://t.co/pyeiPn5fAX
— Stop Playing💡 (@Chephunme) November 18, 2026
The updated whitepaper also explains the network’s technical features, including its enterprise-grade architecture, Byzantine Fault Tolerant (BFT) consensus mechanism, and block times of approximately 600 milliseconds.
It also covers Injective’s centralized limit order book and sealed batch auctions, which are designed to support trading and financial applications on the network. These features are important as Injective seeks to meet the technical and operational requirements of traditional financial institutions.
Also on X, Marius praised this strategy, observing that Injective is positioning itself at the intersection of traditional finance and real-world asset tokenization.
Injective is positioning itself right at the intersection of traditional finance and real-world assets. injective-protocol:native
— Marius Bolta (@MariusBolta) November 18, 2026
Read also: Injective Community Approves Proposal to Accelerate INJ Supply Reduction
Injective highlights RWA tokenization and AI payment infrastructure
Beyond trading, the updated whitepaper also focuses on Injective’s infrastructure for issuing and settling tokenized real-world assets (RWAs) directly on the blockchain.
It explains how these assets can operate across decentralized markets and software applications. The network also aims to support financial transactions between autonomous AI agents, potentially making it a financial infrastructure layer for emerging AI-powered economies.
Injective’s support for both Ethereum Virtual Machine (EVM) and WebAssembly (WASM) gives developers more flexibility when building applications. This compatibility allows enterprise developers to create applications that work across different environments.
However, despite the Nasdaq-listed ETF and updated technical documentation, INJ has faced recent pressure from broader market conditions. The token is currently trading at approximately $7.35.
Max Size on X questioned whether the whitepaper update could have an immediate effect on the market, asking whether the release could push INJ’s ETF performance higher.
@injective Could this whitepaper lift INJ’s ETF skyward
— MaxSize (@maxsizehpx02) November 18, 2026
Although technical documentation does not typically trigger immediate price increases, the updated whitepaper could help investors better understand Injective’s long-term plans.
By providing clearer information about its infrastructure for tokenized real-world assets and AI-powered financial applications, Injective is seeking to establish the technical foundation needed to attract institutional investment over the coming years.
Enjoyed this? Bookmark DeFi Planet, explore related topics, and follow us on Twitter, LinkedIn, Facebook, Instagram, Threads, and CoinMarketCap Community for seamless access to high-quality industry insights.
Take control of your crypto portfolio with DEFI PLANET PRO, DeFi Planet’s suite of analytics tools.



























































































